Covington & Burling represented uniQure in the transaction. uniQure N.V. (NASDAQ: QURE), a leading gene therapy company, announced the closing of the sale of its global...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here